Insulin Pump-RT Advisor (IPRA©): a Decision Support Software for Diabetic Patients Treated by Insulin Pump and Using Continuous Glucose Monitoring. Experimental Study. Evaluation by an Expert Patient Panel. (IPRA)
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT01883024|
Recruitment Status : Completed
First Posted : June 21, 2013
Last Update Posted : September 17, 2013
|Condition or disease||Intervention/treatment||Phase|
|Type 1 Diabetes||Other: A decision support software Other: Insulin Pump Other: Continuous glucose monitoring||Not Applicable|
|Study Type :||Interventional (Clinical Trial)|
|Actual Enrollment :||6 participants|
|Intervention Model:||Single Group Assignment|
|Masking:||None (Open Label)|
|Official Title:||Prospective Study, Insulin Pump-RT Advisor (IPRA©): a Decision Support Software for Diabetic Patients Treated by Insulin Pump and Using Continuous Glucose Monitoring. Experimental Study. Evaluation by an Expert Patient Panel.|
|Study Start Date :||June 2013|
|Actual Primary Completion Date :||July 2013|
|Actual Study Completion Date :||September 2013|
|Type 1 diabetes||
Other: A decision support software
Other: Insulin Pump
Other: Continuous glucose monitoring
- Patient agreement with the IPRA© advices: global rate of agreement, according to advice subtypes, according to blood glucose levels, according to the situations (pre or post-meal, bedtime) [ Time Frame: 3 months ]Assessment of the relevance of the advices provided by the IPRA© smartphone application for guiding the responses of insulin pump treated type 1 diabetes patients using real-time continuous glucose monitoring.
- Assessment of similarity between patient decisions and IPRA© advices [ Time Frame: 3 months ]
Assessment of patient satisfaction about using IPRA© and their frequency of use.
Recording of the changes proposed by the expert patients.
- Assessment of changes proposed by the experts [ Time Frame: 3 months ]
- Assessment of frequency of software use [ Time Frame: 3 months ]
- Assessment of patient satisfaction [ Time Frame: 3 months ]
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01883024
|Service d'Endocrinologie-Diabétologie - CHU de Rennes - Hôpital Sud|
|Rennes, France, 35230|
|Principal Investigator:||Isabelle Guilhem||Rennes University Hospital|